Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Norton%2C+Thomas%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22Norton%2C+Thomas%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22Norton%2C+Thomas%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (10)
1
Thematic analysis to explore patients' experiences with long COVID-19 : a conceptual model of symptoms and impacts on daily lives
enthalten in:
BMJ open
| 2024
von
Rofail, D.
|
Somersan-Karakaya, S.
|
Choi, J.
| +7
Wird geladen...
2
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles
enthalten in:
Scientific reports
| 2023
von
Li, D.
|
Xu, M.
|
Hooper, A.
| +9
Wird geladen...
3
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection : A Phase 2 Dose-Ranging Randomized Clinical Trial
enthalten in:
JAMA network open
| 2022
von
Portal-Celhay, C.
|
Forleo-Neto, E.
|
Eagan, W.
| +127
Wird geladen...
4
REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 Outpatients
enthalten in:
bioRxiv.org
| 2022
von
Weinreich, D.
|
Sivapalasingam, S.
|
Norton, T.
| +36
Wird geladen...
5
REGEN-COV Antibody Combination in Outpatients With COVID-19 – Phase 1/2 Results
enthalten in:
bioRxiv.org
| 2022
von
Norton, T.
|
Ali, S.
|
Sivapalasingam, S.
| +33
Wird geladen...
6
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
enthalten in:
The New England journal of medicine
| 2021
von
Weinreich, D.
|
Sivapalasingam, S.
|
Norton, T.
| +138
Wird geladen...
7
Phase 2 dose-ranging study of the virologic efficacy and safety of the combination COVID-19 antibodies casirivimab and imdevimab in the outpatient setting
enthalten in:
bioRxiv.org
| 2021
von
Portal-Celhay, C.
|
Forleo-Neto, E.
|
Eagan, W.
| +26
Wird geladen...
8
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
enthalten in:
Cell
| 2021
von
Copin, R.
|
Baum, A.
|
Wloga, E.
| +34
Wird geladen...
9
REGEN-COV protects against viral escape in preclinical and human studies
enthalten in:
bioRxiv.org
| 2021
von
Copin, R.
|
Baum, A.
|
Wloga, E.
| +34
Wird geladen...
10
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
enthalten in:
The New England journal of medicine
| 2021
von
Weinreich, D.
|
Sivapalasingam, S.
|
Norton, T.
| +131
CommentIn: N Engl J Med. 2021 Jan 21;384(3):289-291. - PMID 33471984
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
10
Aufsätze
10
E-Artikel
10
E-Ressourcen
Zeitschriftentitel
4
bioRxiv.org
2
The New England journal of medicine
1
BMJ open
1
Cell
1
JAMA network open
1
Scientific reports
Alle anzeigen ...
weniger ...
Thema
6
Journal Article
5
Randomized Controlled Trial
5
Research Support, Non-U.S. Gov't
4
Antibodies, Monoclonal, Humanized
3
Antibodies, Neutralizing
3
Clinical Trial, Phase II
3
Multicenter Study
3
casirivimab and imdevimab drug combination
2
2Z3DQD2JHM
2
COVID-19
2
Clinical Trial, Phase I
2
Clinical Trial, Phase III
2
Drug Combinations
2
J0FI6WE1QN
2
casirivimab
2
imdevimab
1
Antibodies, Monoclonal
1
Antibodies, Viral
1
Antiviral Agents
1
INFECTIOUS DISEASES
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
1
2023
3
2022
5
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10
Englisch
Haven't found what you're looking for?
Wird geladen...